The study investigated whether percutaneous partial pressure of oxygen (PtcO2), percutaneous partial pressure of carbon dioxide (PtcCO2), and the derived tissue perfusion index (TPI) can predict the severity and short-term outcomes of severe and critical COVID-19.
Design
Prospective observational study conducted from January 1, 2023 to February 10, 2023.
Setting
A teaching hospital specializing in tertiary care in Nanjing City, Jiangsu Province, China.
Participants
Adults (≥18 years) with severe and critical COVID-19.
Interventions
Not applicable.
Main outcome measures
The general information and vital signs of the patients were collected. The PtcO2 and PtcCO2 were monitored in the left dorsal volar. The ratio of TPI was defined as the ratio of PtcO2/fraction of inspired oxygen (FiO2) to PtcCO2. Mortality at 28 was recorded. The ability of the TPI to assess disease severity and predict prognosis was determined.
Endpoint
Severity of the disease on the enrollment and mortality at 28.
Results
A total of 71 patients with severe and critical COVID-19, including 40 severe and 31 critical cases, according to the COVID-19 treatment guidelines published by WHO, were recruited. Their median age was 70 years, with 56 (79%) males. The median SpO2/FiO2, PtcO2, PtcCO2, PtcO2/ FiO2, and TPI values were 237, 61, 42, 143, and 3.6 mm Hg, respectively. Compared with those for severe COVID-19, the TPI, PtcO2/ FiO2, SpO2/FiO2, and PtcO2 were significantly lower in critical COVID-19, while the PtcCO2 was significantly higher. After 28 days, 26 (37%) patients had died. TPI values < 3.5 were correlated with more severe disease status (AUC 0.914; 95% CI: 0.847-0.981, P < 0.001), and TPI < 3.3 was associated with poor outcomes (AUC 0.937; 95% CI 0.880-0.994, P < 0.001).
Conclusions
The tissue perfusion index (TPI), PtcCO2, and PtcO2/ FiO2 can predict the severity and outcome of severe and critical COVID-19.
HuangCWangYLiX, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5
3.
XieJWuWLiS, et al.Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: A retrospective multicenter study. Intensive Care Med. 2020;46(10):1863–1872. doi:https://doi.org/10.1007/s00134-020-06211-2
4.
XieJTongZGuanXDuBQiuHSlutskyAS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020;46(5):837–840. doi:https://doi.org/10.1007/s00134-020-05979-7
VerasFPGomesGFSilvaBMS, et al.Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respir Res. 2023;24(1):66. doi:https://doi.org/10.1186/s12931-023-02336-2
8.
Lopes-PachecoMSilvaPLCruzFF, et al.Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front Physiol. 2021;12:593223. doi:https://doi.org/10.3389/fphys.2021.593223
SaugelBVincentJL. Cardiac output monitoring: How to choose the optimal method for the individual patient. Curr Opin Crit Care.2018;24(3):165–172. doi:https://doi.org/10.1097/MCC.0000000000000492
11.
BaranDAGrinesCLBaileyS, et al.SCAI Clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv.2019;94(1):29–37. doi:https://doi.org/10.1002/ccd.28329
12.
ThieleHOhmanEMDe Waha-ThieleSZeymerUDeschS. Management of cardiogenic shock complicating myocardial infarction: An update 2019. Eur Heart J.2019;40(32):2671–2683. doi:https://doi.org/10.1093/eurheartj/ehz363
13.
HernandezGPedrerosCVeasE, et al.Evolution of peripheral vs metabolic perfusion parameters during septic shock resuscitation. A clinical-physiologic study. J Crit Care.2012;27(3):283–288. doi:https://doi.org/10.1016/j.jcrc.2011.05.024
TremperKKWaxmanKBowmanRShoemakerWC. Continuous transcutaneous oxygen monitoring during respiratory failure, cardiac decompensation, cardiac arrest, and CPR. Transcutaneous oxygen monitoring during arrest and CPR. Crit Care Med. 1980;8(7):377–381. doi:https://doi.org/10.1097/00003246-198007000-00003
17.
TremperKKShoemakerWC. Transcutaneous oxygen monitoring of critically ill adults, with and without low flow shock. Crit Care Med. 1981;9(10):706–709. doi:https://doi.org/10.1097/00003246-198110000-00007
ShoemakerWCAppelPLKramHBNathanRCThompsonJL. Multicomponent noninvasive physiologic monitoring of circulatory function. Crit Care Med. 1988;16(5):482–490. doi:https://doi.org/10.1097/00003246-198805000-00004
21.
ThangathuraiDCharbonnetCRoesslerP, et al.Continuous intraoperative noninvasive cardiac output monitoring using a new thoracic bioimpedance device. J Cardiothorac Vasc Anesth. 1997;11(4):440–444. doi:https://doi.org/10.1016/s1053-0770(97)90052-5
22.
ShoemakerWCWoCCDemetriadesD, et al.Early physiologic patterns in acute illness and accidents: Toward a concept of circulatory dysfunction and shock based on invasive and noninvasive hemodynamic monitoring. New Horiz. 1996;4(4):395–412.
ShoemakerWCBelzbergHWoCC, et al.Multicenter study of noninvasive monitoring systems as alternatives to invasive monitoring of acutely ill emergency patients. Chest. 1998;114(6):1643–1652. doi:https://doi.org/10.1378/chest.114.6.1643
25.
TatevossianRGWoCCJVelmahosGCDemetriadesDShoemakerWC. Transcutaneous oxygen and CO2 as early warning of tissue hypoxia and hemodynamic shock in critically ill emergency patients. Crit Care Med.2000;28(7):2248–2253. doi:https://doi.org/10.1097/00003246-200007000-00011
26.
TonelliARAlkukhunLCikachFAhmedMDweikRA. Are transcutaneous oxygen and carbon dioxide determinations of value in pulmonary arterial hypertension?Microcirculation. 2015;22(4):249–256. doi:https://doi.org/10.1111/micc.12191
27.
Zawawi ZMKalyanasundramJMohd ZainRThayanRBasriDFYapWB. Prospective roles of tumor necrosis factor-alpha (TNF-α) in COVID-19: Prognosis, therapeutic and management. Int J Mol Sci. 2023;24(7):6142. doi:https://doi.org/10.3390/ijms24076142
28.
LiuLXieJWuW, et al.A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: A retrospective multicentre study. Lancet Digit Health. 2021;3(3):e166–e174. doi:https://doi.org/10.1016/S2589-7500(20)30316-2
29.
RoozemanJPMazzinariGSerpa NetoA, et al.Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19 – insights from the PRoVENT-COVID study. J Crit Care.2022;68:31–37. doi:https://doi.org/10.1016/j.jcrc.2021.11.009
30.
KumarAAggarwalRKhannaP, et al.Correlation of the SpO2/FiO2 (S/F) ratio and the PaO2/FiO2 (P/F) ratio in patients with COVID-19 pneumonia. Medicina Intensiva (English Edition). 2022;46(7):408–410.
KimJHBaekARLeeSI, et al.ROX index and SpO2/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study. PLoS One. 2022;17(5):e0268431. doi:https://doi.org/10.1371/journal.pone.0268431
TobinMJLaghiFJubranA. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356–360. doi:https://doi.org/10.1164/rccm.202006-2157CP
37.
WaxmanKSadlerREisnerMEApplebaumRTremperKKMasonGR. Transcutaneous oxygen monitoring of emergency department patients. Am J Surg. 1983;146(1):35–38. doi:https://doi.org/10.1016/0002-9610(83)90255-6
38.
YuMMoritaSYDanielSRChapitalAWaxmanKSeverinoR. Transcutaneous pressure of oxygen: a noninvasive and early detector of peripheral shock and outcome. Shock. 2006;26(5):450–456. doi:https://doi.org/10.1097/01.shk.0000228798.18174.6a
39.
HansenTNSonodaYMcIlroyMB. Transfer of oxygen, nitrogen, and carbon dioxide through normal adult human skin. J Appl Physiol.1980;49(3):438–443. doi:https://doi.org/10.1152/jappl.1980.49.3.438
40.
AarrestadSTollefsenEKleivenALQvarfortMJanssensJPSkjønsbergOH. Validity of transcutaneous PCO2 in monitoring chronic hypoventilation treated with non-invasive ventilation. Respir Med. 2016;112:112–118. doi:https://doi.org/10.1016/j.rmed.2016.01.017
41.
StorreJHMagnetFSDreherMWindischW. Transcutaneous monitoring as a replacement for arterial PCO2 monitoring during nocturnal non-invasive ventilation. Respir Med. 2011;105(1):143–150. doi:https://doi.org/10.1016/j.rmed.2010.10.007
42.
HuttmannSEWindischWStorreJH. Techniques for the measurement and monitoring of carbon dioxide in the blood. Ann Am Thorac Soc. 2014;11(4):645–652. doi:https://doi.org/10.1513/AnnalsATS.201311-387FR
43.
StorreJHSteurerBKabitzHJDreherMWindischW. Transcutaneous PCO2 monitoring during initiation of noninvasive ventilation. Chest. 2007;132(6):1810–1816. doi:https://doi.org/10.1378/chest.07-1173
44.
GancelPERoupieEGuittetLLaplumeSTerziN. Accuracy of a transcutaneous carbon dioxide pressure monitoring device in emergency room patients with acute respiratory failure. Intensive Care Med. 2011;37(2):348–351. doi:https://doi.org/10.1007/s00134-010-2076-1
45.
GeorgesMRabecCMoninE, et al.Monitoring of noninvasive ventilation: Comparative analysis of different strategies. Respir Res. 2020;21(1):324. doi:https://doi.org/10.1186/s12931-020-01586-8
46.
NassarBMallatJ. CO2-derived Variables for hemodynamic management in critically ill patients. J Thorac Dis. 2019;11(Suppl 11):S1525–S1527. doi:https://doi.org/10.21037/jtd.2019.04.94
47.
GeorgesMNguyen-BaranoffDGriffonL, et al.Usefulness of transcutaneous PCO2 to assess nocturnal hypoventilation in restrictive lung disorders. Respirology. 2016;21(7):1300–1306. doi:https://doi.org/10.1111/resp.12812
48.
WijesingheMPerrinKHealyBWeatherallMBeasleyR. Randomized controlled trial of high concentration oxygen in suspected community-acquired pneumonia. J R Soc Med. 2012;105(5):208–216. doi:https://doi.org/10.1258/jrsm.2012.110084
49.
SchwarzSBWindischWMagnetFS, et al.Continuous non-invasive PCO2 monitoring in weaning patients: Transcutaneous is advantageous over end-tidal PCO2. Respirology. 2017;22(8):1579–1584. doi:https://doi.org/10.1111/resp.13095
50.
ShoemakerWCThangathuraiDWoCC, et al.Intraoperative evaluation of tissue perfusion in high-risk patients by invasive and noninvasive hemodynamic monitoring. Crit Care Med. 1999;27(10):2147–2152. doi:https://doi.org/10.1097/00003246-199910000-00012
51.
TatevossianRGWoCCVelmahosGCDemetriadesDShoemakerWC. Transcutaneous oxygen and CO2 as early warning of tissue hypoxia and hemodynamic shock in critically ill emergency patients. Crit Care Med. 2000;28(7):2248–2253. doi:https://doi.org/10.1097/00003246-200007000-00011
52.
ShoemakerWCWoCCChanL, et al.Outcome prediction of emergency patients by noninvasive hemodynamic monitoring. Chest. 2001;120(2):528–537. doi:https://doi.org/10.1378/chest.120.2.528
53.
TatevossianRGShoemakerWCWoCCDangABVelmahosGCDemetriadesD. Noninvasive hemodynamic monitoring for early warning of adult respiratory distress syndrome in trauma patients. J Crit Care. 2000;15(4):151–159. doi:https://doi.org/10.1053/jcrc.2000.19235
TakiwakiHNakanishiHShonoYAraseS. The influence of cutaneous factors on the transcutaneous pO2 and pCO2 at various body sites. Br J Dermatol. 1991;125(3):243–247. doi:https://doi.org/10.1111/j.1365-2133.1991.tb14748.x
56.
VakhterVKahramanBBuGForoozanFGulerU. A prototype wearable device for noninvasive monitoring of transcutaneous oxygen. IEEE Trans Biomed Circuits Syst. 2023;17(2):323–335. doi:https://doi.org/10.1109/TBCAS.2023.3251321
57.
CostanzoISenDAdegiteJRaoPMGulerU. A noninvasive miniaturized transcutaneous oxygen monitor. IEEE Trans Biomed Circuits Syst. 2021;15(3):474–485. doi:https://doi.org/10.1109/TBCAS.2021.3094931
58.
CascalesJPLiXRoussakisEEvansCL. A patient-ready wearable transcutaneous CO2 sensor. Biosensors (Basel). 2022;12(5):333. doi:https://doi.org/10.3390/bios12050333
59.
van WeteringenWGoosTGvan EssenT, et al.Novel transcutaneous sensor combining optical tcPO2 and electrochemical tcPCO2 monitoring with reflectance pulse oximetry. Med Biol Eng Comput. 2020;58(2):239–247. doi:https://doi.org/10.1007/s11517-019-02067-x
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
